Medicine and Dentistry
Pediatrics
80%
Pediatric Urology
80%
Non Muscle Invasive Bladder Cancer
68%
Urologist
40%
Recurrent Disease
37%
Mitomycin
33%
Hypospadias
33%
Systematic Review
33%
Urology
31%
Bladder
24%
Cryptorchism
22%
Transurethral Resection
20%
Immunotherapy
17%
Cancer Risk
15%
Percutaneous Nephrolithotomy
15%
Attitude
14%
Cancer Treatment
14%
Intravesical Drug Administration
14%
Transitional Care
14%
Disease
14%
Neoplasm
13%
Bacilli
13%
Cystectomy
13%
Heat Therapy
13%
Recurrence Free Survival
13%
Cross Sectional Study
12%
Bladder Cancer
12%
Observational Study
11%
Vesicoureteral Reflux
11%
Replantation
11%
Keyhole Limpet Hemocyanin
11%
Protocol Compliance
11%
Kidney Injury
11%
Epidermal Growth Factor Receptor
11%
Casemix
11%
Hyperthermia
11%
Excitatory Junction Potential
11%
Developmental Disorder
11%
Urolithiasis
11%
Fistula
11%
Urologic Surgery
11%
Pyeloplasty
11%
Urinary System
11%
Bladder Tumor
9%
Smoking
9%
Feces Incontinence
8%
Pediatric Surgery
7%
Major Surgery
7%
Patient with Spina Bifida
7%
General Surgery
7%
Keyphrases
Non-muscle Invasive Bladder Cancer (NMIBC)
34%
Pediatric Urology
31%
Chemohyperthermia
29%
Hyperthermia
22%
Undescended Testis
22%
Roundtable Discussion
22%
Clinical Scenarios
22%
Mitomycin C
18%
Intravesical Chemotherapy
16%
Urologists
16%
European Association of Urology
16%
Intravesical Therapy
12%
Bacillus Calmette
12%
Pediatric
12%
Bladder Cancer Risk
11%
Device Therapy
11%
Combined Regimen
11%
Intravesical Immunotherapy
11%
Human EGF
11%
Clinical Utility
11%
Risk Calculator
11%
Urinary Cytokines
11%
Cystectomy
11%
Developmental Disorders
11%
Neuropsychiatric
11%
Pleural Fistula
11%
Membership Survey
11%
Pediatric Urolithiasis
11%
Survey Panels
11%
Female Representation
11%
Response to Treatment
11%
Bladder Bowel Dysfunction
11%
Multi-institutional
11%
European Society
11%
Laparoscopic Ureteral Reimplantation
11%
Hypospadias
11%
Brainteaser
11%
Laparoscopic Pyeloplasty in children
11%
Laparoscopic Pyeloplasty
11%
ERAS Guidelines
11%
Urethral Polyp
11%
Percutaneous Nephrolithotomy
11%
Fecal Incontinence
11%
Bladder Pain Syndrome
9%
Bowel Dysfunction
9%
Parous Women
9%
Nulliparous Women
9%
Risk Table
8%
Constipation
7%
Prevent Recurrence
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Muscle Invasive Bladder Cancer
100%
Recurrent Disease
46%
Chemotherapy
38%
Mitomycin
33%
Hyperthermia
22%
Adverse Event
22%
Immunotherapy
16%
Recurrence Free Survival
15%
Bladder Tumor
15%
Bacilli
13%
Observational Study
11%
Cytokine
11%
Chemokine
11%
Hypospadias
11%
Pharmacokinetics
11%
Malignant Neoplasm
11%
Disease
11%
Pharmacodynamics
11%
Developmental Disorder
11%
Keyhole Limpet Hemocyanin
11%
Spinal Dysraphism
11%
Diseases
11%
Nephrolithiasis
11%
Antibiotic Prophylaxis
11%
Kidney Stone
11%
Imiquimod
10%
Tumor Recurrence
6%
Side Effect
5%
Toll Like Receptor 7
5%
